Industry Newsbiologicsmanufacturingucb
UCB Establishes $2bn Biologics Manufacturing Facility
4.8
Relevance ScoreUCB will establish a $2 billion biologics manufacturing facility in Georgia, in the same state as its US headquarters in Smyrna. The new site will produce biologics drawn from the company’s existing portfolio and development pipeline.
Scoring Rationale
Significant capital investment announced, but RSS-only source limits verification and full impact details.
Sources
- Read OriginalUCB banks on Georgia for $2bn biologics manufacturing facilityfinance.yahoo.com
